SHH · 603538.SS
Ningbo Menovo Pharmaceutical Co., Ltd.
CN¥21.34+CN¥1.06 (+5.23%)
Ningbo Menovo Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 57.6% below the high.
Loading market information…
SHZ · 002728.SZ · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 05:10 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Teyi Pharmaceutical Group Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 40.57% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Teyi Pharmaceutical Group Co.,Ltd’s forward annual dividend is CN¥0.15 per share, paid annual. The forward yield is 1.66% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Teyi Pharmaceutical Group Co.,Ltd’s next earnings report is currently expected on Apr 28, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Teyi Pharmaceutical Group Co.,Ltd’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Teyi Pharmaceutical Group Co., Ltd. is a Chinese pharmaceutical company that focuses on the development, production, and sale of a broad range of medicinal products within China. Its offerings include both proprietary traditional Chinese medicines (TCMs) and various chemical products, such as finished preparations, raw materials, and other related chemical compounds. The company's portfolio of finished drugs targets several key therapeutic areas, including respiratory conditions (like cough and phlegm), kidney-related ailments, infectious diseases, cardiovascular issues, and digestive system disorders. Beyond finished medications, Teyi Pharmaceutical also supplies a variety of chemical raw materials and products; notable examples include aluminum magnesium carbonate, phenytoin, ferrous sulfate, glacial acetic acid, calcium chloride, sodium chloride, bismuth and citric acid series compounds, and zinc sulfate. Based in Taishan, China, the company underwent a name change in November 2016, transitioning from its previous identity as Guangdong Taicheng Pharmaceutical Co., Ltd. to its current name, Teyi Pharmaceutical Group Co., Ltd.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:27 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q4 2024 | Mar 28, 2025 | CN¥0.03 | CN¥232.19M |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥21.34+CN¥1.06 (+5.23%)
Ningbo Menovo Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 57.6% below the high.
CN¥11.53+CN¥0.38 (+3.41%)
Jiangsu Yahong Meditech Co Ltd’s quoted price sits in the lower half of its reported 52-week range, 35.89% below the high.
CN¥7.02+CN¥0.24 (+3.54%)
Jinghua Pharmaceutical Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.49% below the high.
CN¥8.78+CN¥0.22 (+2.57%)
HPGC Renmintongtai Pharmaceutical Corporation’s quoted price sits in the lower half of its reported 52-week range, 51.52% below the high.
CN¥4.09+CN¥0.10 (+2.51%)
Luoxin Pharmaceuticals Group Stock Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 29.55% below the high.
CN¥3.63+CN¥0.08 (+2.25%)
Fuan Pharmaceutical (Group) Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 27.4% below the high.
CN¥26.58+CN¥0.32 (+1.22%)
Jianmin Pharmaceutical Group Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 33.85% below the high.
CN¥7.95+CN¥0.30 (+3.92%)
Beijing Science Sun Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 42.39% below the high.
